By Colin Kellaher Eli Lilly & Co. on Friday said the European Medicines Agency s Committee for Medicinal Products for Human Use issued a positive scientific opinion for the company s antibody-based Covid-19 drugs aimed at helping people at high risk of severe disease avoid hospitalization. The Indianapolis drugmaker said the opinion covers its monoclonal antibody bamlanivimab alone and in combination with one named etesevimab for the treatment of confirmed Covid-19 in patients ages 12 years and older who don t need supplemental oxygen and are at high risk of progressing to severe Covid-19. Monoclonal antibodies are engineered proteins that mimic the immune system s ability to fight off viruses.
东莞清溪医院挂牌成教学医院，异地新建医院纳入镇 十四五 oeeee.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from oeeee.com Daily Mail and Mail on Sunday newspapers.
Date Time
ACEM statement on Royal Commission into Aged Care Quality and Safety
The Australasian College for Emergency Medicine (ACEM; the College) acknowledges the release of the Royal Commission into Aged Care Quality and Safety’s final report and supports its intent of developing a new rights-based aged care system.
With the Royal Commission having highlighted many deeply disturbing issues and problems with the way older people are cared for in this country, the report must be a catalyst for improvements in the way some of our society’s most vulnerable receive healthcare.
Older people deserve access to timely, affordable, appropriate and high-standard healthcare. Where feasible and appropriate, this should be delivered in the environment of their choice – be it their own home, hospital, or residential aged care facility (RACF). ACEM hopes the release of the final report, and the implementation of its recommendations, will help achieve improvements to systems which have fa
(1)
The trial assesses the safety and efficacy of the IUB SEAD, a disruptive treatment for AUB. In this study, 50% of the participating patients have reached the End of the Study point, demonstrating a significant reduction in bleeding, avoiding the need to undergo invasive uterine ablation procedures or even a hysterectomy
MODIIN, Israel, March 4, 2021 /PRNewswire/
OCON Healthcare, a women s health company which develops, manufactures and commercializes an innovative 3D intrauterine drug delivery technology based on its patented IUB
TM (Intra Uterine Ball) platform, today announced it had completed enrollment of its Phase IIa clinical study evaluating its intrauterine drug delivery platform IUB SEAD,a non-invasive treatment for abnormal uterine bleeding (AUB).
Improving nurse staffing in New York hospitals could reduce deaths, save money
According to a new study published in
Medical Care, improving hospital nurse staffing as proposed in pending legislation in New York state would likely save lives. The cost of improving nurse staffing would be offset by savings achieved by reducing hospital readmissions and length of hospital stays.
Researchers at the Center for Health Outcomes and Policy Research (CHOPR) at the University of Pennsylvania School of Nursing, conducted independent research in early 2020 on whether pending nurse staffing legislation in New York state is in the public s interest. The study of 116 hospitals and 418,000 Medicare patients documented large differences in patient-to-nurse ratios by hospital from an average of 4.3 patients for each nurse to as many as 10.5 patients per nurse. The wide variation in patient-to-nurse ratios across hospitals in New York is contributing to avoidable deaths and unnecessary costs.